鉴定用于基因治疗的活性和抑制剂耐药MGMT变体
Ana Cheong1, Adam Fisher2, Ashvin Bashyam2
1Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
American journal of human genetics
|May 21, 2025
概括
研究人员发现了新的O6-甲基氨酸-DNA甲基转移酶 (MGMT) 变体,耐受抑制剂. 这一发现使得血液造血干细胞 (HSC) 中的基因编辑能够得到增强,用于治疗应用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- O6-甲基瓜氨酸-DNA甲基转移酶 (MGMT) 修复了BCNU等化剂造成的DNA损伤.
- MGMT是由O6-基氨酸 (O6BG) 抑制的,但Pro140Lys (P140K) 变种表现出耐药性.
- 目前的基因编辑方法难以将P140K变体引入血造干细胞 (HSC).
研究的目的:
- 为了确定抗O6BG和易受基因编辑的新型MGMT变异.
- 开发一个查平台,以发现功能性DNA修复蛋白质变体.
- 为了使基因修改HSCs在体内丰富,用于治疗策略.
主要方法:
- 计算分析来选择潜在的MGMT变体.
- 创建一个MGMT变异表达等离子体 (pMGMTs) 的库.
- 在MGMT缺乏的U251细胞中使用O6BG,pMGMT和记者等离子体 (mPlum_O6MeG) 的功能查,然后进行流细胞计.
- 使用第二种抑制剂PaTrin-2进行验证.
主要成果:
- 通过基于细胞的查确定了活性和O6BG耐药的MGMT变体.
- 通过使用PaTrin-2确认了变体活性和抑制剂耐药性.
- 发现了自然存在的MGMT变体,它们是活性和O6BG敏感的.
- 建立了MGMT变种的功能数据库.
结论:
- 开发了一个基于细胞的平台来选DNA修复蛋白质.
- 确定了新的MGMT变体,在基因编辑HSC中具有治疗应用的潜力.
- 这些发现为改进的基因编辑策略铺平了道路,这些策略针对的是DNA修复机制.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


